Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

PRKACB – Ellis-van Creveld syndrome

In a cohort of 45 autosomal recessive Ellis-van Creveld syndrome families, biallelic variants in PRKACB were identified in one family (2.2%) (PMID:35927022). No detailed variant descriptions were provided for PRKACB, and additional segregation beyond the proband was not reported, precluding assessment of familial transmission. Functional studies directly linking PRKACB disruption to the Ellis-van Creveld phenotype are absent, and no genotype–phenotype correlations or recurrent alleles in PRKACB have been established within this context. Taken together, current evidence for PRKACB as a causative gene in Ellis-van Creveld syndrome remains limited.

Key take-home: PRKACB should be considered a tentative, low-frequency contributor to Ellis-van Creveld syndrome, warranting further genetic and functional validation before incorporation into diagnostic panels.

References

  • Unknown • 2022 • Molecular characterization of Ellis-Van Creveld syndrome genetic heterogeneity PMID:35927022

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

PRKACB variants identified in 1 of 45 families (2.2%) (PMID:35927022)

Genetic Evidence

Limited

Single AR proband with biallelic PRKACB involvement; no segregation or detailed variant data

Functional Evidence

No evidence

No functional or experimental studies of PRKACB in Ellis-van Creveld syndrome context